Abstract

Marsha J. Tyson Darling reflects on how new and emerging technology serve ideological, political, social, cultural and gendered interests. She argues progress on social justice and the social norms which are embedded in a public domain is increasingly being sacrificed to legal- and market-based norms in the new genomics-based consumerism that defines the current new and emerging technologies. Her focus is on the gendered dimensions of 'red biotechnologies,' particularly the legacy of using women's bodies and risking women's health to pursue largely unregulated biotechnologies.